Artiva Biotherapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-140.7M | $102.8M |
| FY2023 | — | $-162.0M | $53.5M |
| FY2024 | — | $186.6M | $40.2M |
| FY2025 | — | $110.0M | $26.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $-140.7M | $102.8M |
| FY2023 | — | $-162.0M | $53.5M |
| FY2024 | — | $186.6M | $40.2M |
| FY2025 | — | $110.0M | $26.7M |